Your session is about to expire
← Back to Search
Non-euploid Embryo Transfer for Aneuploidy and Mosaicism (TAME Trial)
TAME Trial Summary
This trial looks at how often embryos that are reported as abnormal by preimplantation genetic testing actually result in a live birth, and whether those babies have any health or developmental issues.
TAME Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTAME Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TAME Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You do not live in the United States.I do not have any healthy embryos for use.I have embryos that are not typical in their chromosome number.My embryos do not have Trisomy 18, Trisomy 13, or Triploidy.You are using a surrogate mother to carry your child.
- Group 1: Non-euploid Transfer
- Group 2: Euploid Transfer
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research initiative seek out individuals above the age of 50?
"This medical trial will include patients that are 18 and older, but below the age of 55."
Are individuals currently being accepted to participate in this experiment?
"This medical experiment, which was initially published on April 11th 2019, is still open and actively looking for participants. The trial's information has been modified most recently on January 27th 2022 according to clinicaltrials.gov."
To whom is this clinical trial open for participation?
"This trial aims to enroll 300 individuals aged 18-55 with aneuploidy. In addition, these participants must have available aneuploid or mosaic embryos, not possess any acceptable euploid specimens, be willing to travel for treatment at Stanford University, and understand English."
To what extent is the current research being conducted involving human participants?
"Affirmative. Information hosted on clinicaltrials.gov displays that the study, which was first advertised on April 11th 2019 is currently recruiting participants; 300 volunteers are needed at a single medical centre for enrollment."
Share this study with friends
Copy Link
Messenger